In addition to PD-L1, one new protein targeted in melanoma is V domain Ig containing a suppressor of T-cell activation (VISTA), a PD-L1 homologue, which targets myeloid tumoral and inflammatory cells and is being studied worldwide to gain more information about its expression. The gene discussed is CD274; the disease is melanoma.